메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

테크니마크, 새로운 브랜드 아이덴티티 공개…"우리는 삶의 질을 높이는 모든 것을 만든다"

[ 메디채널 기자 ] 애시버로, 노스캐롤라이나주, 2025년 7월 9일 -- 의료•소비재 포장•산업 제조 분야의 세계적인 선도기업인 테크니마크(Technimark)가 8일 새로운 브랜드 아이덴티티를 공개했다. 이번 리브랜딩은 신뢰성과 우수성으로 인정받는 글로벌 제조 분야 리더로 회사의 변화를 반영해 추진됐다. 이 새로운 브랜드 아이덴티티에는 테크니마크의 핵심 가치인 혁신, 품질, 서비스, 지속 가능성, 신뢰가 담겨있다. 또한 의료 분야에서 확대된 회사의 존재감, 소비자 포장 분야에서 유지하고 있는 리더십, 운영의 우수성과 고객 성공을 위한 흔들리지 않는 노력도 강조한다. 크리스 피비(Kris Peavy) 테크니마크 의료 부문 최고상업책임자(COO) 겸 사장은 "우리는 단순히 브랜드의 외형만 새롭게 바꾼 게 아니다"라며 "오늘의 우리와 내일의 방향을 보여주는 선언을 한 것"이라고 말했다. 그는 이어 "우리의 새로운 브랜드 아이덴티티는 진정한 솔루션 파트너로서 우리가 얼마나 가치가 있는 존재인지를 보여준다"면서 "우리는 고객과 함께 도전을 극복하고, 혁신적
- 기자
- 2025-07-09 18:45
SBS Partners with National Cancer Society of Malaysia to Champion Healthier, More Responsible Workplaces Across 100 Companies

KUALA LUMPUR, Malaysia, July 9, 2025 -- In a significant move to advance corporate wellness and social responsibility, SBS Digital Holdings Sdn Bhd (SBS Group) has signed a strategic partnership with the National Cancer Society of Malaysia (NCSM). This landmark collaboration aims to mobilize at least 100 companies within the next 12 months to foster healthier, more compassionate workplaces across Malaysia. The Memorandum of Understanding (MoU) was officially inked by Mr. CM Wong, Founder of SBS Group, and Dr. Murallitharan, Chief Executive Officer of NCSM. The partnership marks
- 기자
- 2025-07-09 17:33
Gozellix Receives Permanent HCPCS Code

MELBOURNE, Australia, July 9, 2025 -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that its next-generation PSMA[1] PET[2] imaging agent, Gozellix® (kit for the preparation of gallium-68 (68Ga) gozetotide injection), has been granted a permanent Healthcare Common Procedure Coding System (HCPCS) code by the U.S. Centers for Medicare & Medicaid Services (CMS). Effective from 1 October 2025, CMS and commercial health insurers will recognise the HCPCS Level II code A9616 assigned for reimbursement of Gozellix. The a
- 기자
- 2025-07-09 12:41
Watson-Marlow Fluid Technology Solutions focuses on BioClamp's sustainability benefits and new WMArchitect Interchangeable Parts service at INTERPHEX Tokyo 2025

TOKYO, July 9, 2025 -- Visitors to the Watson-Marlow Fluid Technology Solutions booth W15-2 at INTERPHEX Tokyo 2025 (July 9-11 at Tokyo Big Sight, Japan) can learn more about the new WMArchitect Interchangeable Parts service as well as how recently advanced manufacturing of BioClamp is bringing sustainability benefits to users. The single-use sanitary BioClamp®, from BioPure, has been re-engineered in both its design and manufacturing process. Visitors to booth 15-2 can discover how BioClamp is manufactured to be 13% lighter than the previous model, with a 26% reduction in
- 기자
- 2025-07-09 11:30
First Patient Dosed in Phase 1/2 Clinical Study of Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-1418

SHANGHAI, July 9, 2025 -- Duality Biotherapeutics' ("DualityBio", HKEX:09606) partner Avenzo Therapeutics, Inc. ("Avenzo"), a clinical-stage biotechnology company developing next-generation oncology therapies, today announced the first patient has been dosed in the Phase 1 portion of a Phase 1/2 clinical study evaluating AVZO-1418/DB-1418, a potential best-in-class, novel EGFR/HER3 bispecific antibody-drug conjugate (ADC), in patients with advanced solid tumors. On January 7th, 2025, DualityBio and Avenzo announced that they have entered into a
- 기자
- 2025-07-09 11:14
Spiber Inc. and Iris van Herpen Unite for a Visionary Collaboration at Paris Haute Couture Fashion Week AW2025

YAMAGATA, Japan, July 9, 2025 -- At the forefront of high fashion and biomaterial innovation, Japanese biotech venture Spiber, a pioneer in man-made protein fiber, and acclaimed Dutch haute couture designer Iris van Herpen together unveiled one of the designer's two bridal looks during Paris Haute Couture Fashion Week Autumn/Winter 2025. This partnership represents a powerful dialogue between science and art—two pioneering voices united by a shared aspiration to redefine the future of fashion. Both founded in 2007, Spiber and Iris van Herpen have followed parallel path
- 기자
- 2025-07-09 10:00
Erin M. Schuman Wins 2026 Nakasone Award for Discovery on Neural Synapse Function and Change During Formation of Memories

STRASBOURG, France, July 9, 2025 -- The International Human Frontier Science Program Organization (HFSPO) is pleased to award the 2026 HFSP Nakasone Award to Erin Schuman for her breakthrough related to the function and plasticity of neuronal synapses, their mRNA triggered function, and change during memory formation. Schuman's groundbreaking research revealed that proteins critical for neuron communication, plasticity and memory storage, are produced locally at synapses, the junctions between neurons. This insight overturns the previous belief that a
- 기자
- 2025-07-09 08:00
BiomeNrich™ PRO G814 & PRO G952: Globally Recognized Bifidobacterium Solutions Now Targeting Southeast Asia's Wellness Market

SEOUL, South Korea, July 9, 2025 -- As Southeast Asia's health and wellness market rapidly evolves, consumer expectations are shifting toward multifunctional solutions that go beyond basic digestion. Gut health is now understood as the foundation for immune support, skin clarity, mental balance, and even healthy aging. Among the key microbiome species for gut health, Bifidobacterium bifidum and B. animalis subsp. lactis have emerged as central players in this transformation. Recognizing this growing need for targeted probiotic innovation, CJ BIO has introduced two new
- 기자
- 2025-07-09 07:00
존슨앤드존슨, 아시아 태평양 지역에서 베리펄스™ 플랫폼 출시로 심방세동 치료 혁신 선도

-- 베리펄스™ 플랫폼, 카토™ 3 전기해부학적 매핑 시스템과 완전히 통합된 최초의 PFA 시스템으로, 효율성•재현성•시술 정확도를 향상시키기 위해 설계돼1,i,ii,iii,iv,v,vi,vii,viii,ix -- 베리펄스™ 플랫폼은 한국, 중국, 일본, 홍콩, 호주, 대만에서 승인 어바인, 캘리포니아주, 2025년 7월 9일 -- 심장 부정맥 치료 분야 글로벌 선도기업인 존슨앤드존슨 메드테크(Johnson & Johnson MedTech)가 8일 베리펄스(VARIPULSE™) 플랫폼을 아시아•태평양 지역에서 출시한다고 밝혔다. 베리펄스는 심방세동(AFib) 치료를 위한 카테터 절제술을 수행하는 데 사용된다. 심방세동은 비정상적이고 조절되지 않은 전기 신호가 발생해 불규칙하고 빠른 심장박동을 유발하는 질환이다.x 심방세동은 심장 구조에 변화가 생기게 하는 기저 질환 및 생활 습관과 연관되어 있다.x,xi 이는 뇌졸중, 심부전, 사망 위험을 크게 증가시킨다. 베리펄스™ 플랫폼은 카토 3(CARTO™ 3) 시스템과 하나의 통합된 작업 흐름을 통해 절제와 매핑 작업을 간소화하도록 설계된 최초의 펄스장 절
- 기자
- 2025-07-09 00:11
Technimark Unveils New Brand Identity: "We Make What Makes Life Better"

ASHEBORO, N.C., July 9, 2025 -- Technimark, a world leader in manufacturing for healthcare, consumer packaging, and industrial sectors, today launched a new brand identity to reflect the company's transformation into a global manufacturing leader, known for its reliability and excellence. This new brand identity reflects Technimark's core values: innovation, quality, service, sustainability, and trust. It also underscores the company's expanded presence in the healthcare sector, its continued leadership in consumer packaging, and its unwavering focus on operational excellence and custo
- 기자
- 2025-07-09 00:00

이전

51 52 53 54 55 56 57 58 59 60

많이 본 기사

최근기사

2025-09-09_TUE

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 09월 09일 10시 40분